An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis

A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation

NCT04656275 ·Status: TERMINATED ·Phase: PHASE1

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

NCT07201051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis

NCT03903913 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems

NCT07023354 ·Status: RECRUITING ·Phase: PHASE1

Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB)

NCT04643587 ·Status: COMPLETED ·Phase: PHASE1

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

NCT05846230 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

NCT06872892 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis

NCT01818544 ·Status: COMPLETED ·Phase: PHASE2

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

NCT06280391 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

NCT06559150 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection

NCT05616221 ·Status: COMPLETED ·Phase: PHASE2

A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0001)

NCT05354453 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

NCT05975983 ·Status: RECRUITING ·Phase: PHASE2

Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis

NCT02081963 ·Status: COMPLETED ·Phase: PHASE4

Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis

NCT05743946 ·Status: COMPLETED ·Phase: PHASE4

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

NCT05010577 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis

NCT04596319 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase 2 Study to Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT02538536 ·Status: COMPLETED ·Phase: PHASE2

Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis

NCT02509091 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)

NCT05865886 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

NCT01315691 ·Status: WITHDRAWN ·Phase: PHASE3

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

NCT00930982 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)

NCT00128492 ·Status: COMPLETED ·Phase: PHASE3

Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa

NCT06238856 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT05938920 ·Status: COMPLETED ·Phase: PHASE2